Emmaus Life Sciences, Inc.
OTC: EMMA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Willis C. Lee
- Employees
- 34
- Headquarters
- Torrance, United States
- IPO year
- 2000
- Market cap
- $842.3K
- Website
- https://www.emmausmedical.com
Loading EMMA…
Loading profile data…Frequently asked questions about EMMA
What does Emmaus Life Sciences, Inc. (EMMA) do?
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical enterprise dedicated to the discovery, development, commercialization, and sale of treatments and therapies, primarily addressing rare and orphan diseases across the United States and internationally. The company's flagship product is Endari, an L-glutamine oral powder designed t...
Where does EMMA trade?
Emmaus Life Sciences, Inc. (EMMA) trades on the Other OTC.
What sector is EMMA in?
Emmaus Life Sciences, Inc. (EMMA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Emmaus Life Sciences, Inc.?
Willis C. Lee is the chief executive officer of Emmaus Life Sciences, Inc. (EMMA).
Where is Emmaus Life Sciences, Inc. headquartered?
Emmaus Life Sciences, Inc. is headquartered in United States.
Does EMMA pay a dividend?
Emmaus Life Sciences, Inc. (EMMA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EMMA go public?
Emmaus Life Sciences, Inc. (EMMA) completed its initial public offering in 2000.